Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Pharmacological evaluation and forensic case series of N-pyrrolidino etonitazene (etonitazepyne), a newly emerging 2-benzylbenzimidazole ‘nitazene’ synthetic opioid
Marthe M. Vandeputte, Alex J. Krotulski, Donna Walther, et al.
Archives of Toxicology (2022) Vol. 96, Iss. 6, pp. 1845-1863
Open Access | Times Cited: 50

Showing 1-25 of 50 citing articles:

New Psychoactive Substances Intoxications and Fatalities during the COVID-19 Epidemic
Alfredo Fabrizio Lo Faro, Diletta Berardinelli, Tommaso Cassano, et al.
Biology (2023) Vol. 12, Iss. 2, pp. 273-273
Open Access | Times Cited: 23
Fact vs. fiction: naloxone in the treatment of opioid-induced respiratory depression in the current era of synthetic opioids
Albert Dahan, Thomas S. Franko, James W. Carroll, et al.
Frontiers in Public Health (2024) Vol. 12
Open Access | Times Cited: 14
Pharmacologic Characterization of Substituted Nitazenes atμ,κ, andΔOpioid Receptors Suggests High Potential for Toxicity
Laura B. Kozell, Amy J. Eshleman, Katherine M. Wolfrum, et al.
Journal of Pharmacology and Experimental Therapeutics (2024) Vol. 389, Iss. 2, pp. 219-228
Open Access | Times Cited: 13
Human metabolism of four synthetic benzimidazole opioids: isotonitazene, metonitazene, etodesnitazene, and metodesnitazene
Omayema Taoussi, Diletta Berardinelli, Simona Zaami, et al.
Archives of Toxicology (2024) Vol. 98, Iss. 7, pp. 2101-2116
Open Access | Times Cited: 13
In vitro, in vivo metabolism and quantification of the novel synthetic opioid N-piperidinyl etonitazene (etonitazepipne)
Diletta Berardinelli, Omayema Taoussi, Jérémy Carlier, et al.
Clinical Chemistry and Laboratory Medicine (CCLM) (2024) Vol. 62, Iss. 8, pp. 1580-1590
Closed Access | Times Cited: 10
In vitro structure–activity relationships and forensic case series of emerging 2-benzylbenzimidazole ‘nitazene’ opioids
Liam M. De Vrieze, Sara E. Walton, Eline Pottie, et al.
Archives of Toxicology (2024) Vol. 98, Iss. 9, pp. 2999-3018
Open Access | Times Cited: 10
Identification of N‐pyrrolidino protonitazene in powders sold as heroin and associated with overdose clusters in Dublin and Cork, Ireland
Sarah Killoran, Sinéad McNamara, Pierce V. Kavanagh, et al.
Drug Testing and Analysis (2024)
Closed Access | Times Cited: 9
The Development of a Highly Sensitive Liquid Chromatography–Tandem Mass Spectrometry (LC-MS/MS) Method for the Validation of Flualprazolam and Isotonitazene in Serum
Murat Akbaba, Aysun Baransel Isır
Applied Sciences (2025) Vol. 15, Iss. 5, pp. 2267-2267
Open Access | Times Cited: 1
Early identification of the use of potent benzylbenzimidazoles (nitazenes) through wastewater analysis: Two years of data from 22 countries
Richard Bade, Dhayaalini Nadarajan, Wayne Hall, et al.
Addiction (2025)
Open Access | Times Cited: 1
Discriminative stimulus and antinociceptive effects of sixteen nitazene analogs in rodents
Michael B. Gatch, Rebecca Hill, Megana Sundar, et al.
Neuropharmacology (2025), pp. 110416-110416
Closed Access | Times Cited: 1
First identification, chemical analysis and pharmacological characterization of N-piperidinyl etonitazene (etonitazepipne), a recent addition to the 2-benzylbenzimidazole opioid subclass
Marthe M. Vandeputte, Nick Verougstraete, Donna Walther, et al.
Archives of Toxicology (2022) Vol. 96, Iss. 6, pp. 1865-1880
Closed Access | Times Cited: 31
Comparative neuropharmacology of structurally distinct non-fentanyl opioids that are appearing on recreational drug markets worldwide
Marthe M. Vandeputte, Meng-Hua M. Tsai, Li Chen, et al.
Drug and Alcohol Dependence (2023) Vol. 249, pp. 109939-109939
Closed Access | Times Cited: 22
Non-fentanyl new synthetic opioids – An update
Jolanta B. Zawilska, Piotr Adamowicz, Marta Kurpeta, et al.
Forensic Science International (2023) Vol. 349, pp. 111775-111775
Closed Access | Times Cited: 20
Alkoxy chain length governs the potency of 2-benzylbenzimidazole ‘nitazene’ opioids associated with human overdose
Grant C. Glatfelter, Marthe M. Vandeputte, Li Chen, et al.
Psychopharmacology (2023) Vol. 240, Iss. 12, pp. 2573-2584
Closed Access | Times Cited: 18
In vitro characterization of protonitazene metabolites, using human liver microsomes, and first application to two urines collected from death cases
Alice Ameline, Laurie Gheddar, Simona Pichini, et al.
Clinica Chimica Acta (2024) Vol. 561, pp. 119764-119764
Closed Access | Times Cited: 8
Pharmacological characterization of novel synthetic opioids: Isotonitazene, metonitazene, and piperidylthiambutene as potent μ-opioid receptor agonists
Maria Antonietta De Luca, Graziella Tocco, Rafaela Mostallino, et al.
Neuropharmacology (2022) Vol. 221, pp. 109263-109263
Open Access | Times Cited: 28
Proliferation of Novel Synthetic Opioids in Postmortem Investigations After Core-Structure Scheduling for Fentanyl-Related Substances
Donna M Papsun, Alex J. Krotulski, Barry K. Logan
American Journal of Forensic Medicine & Pathology (2022) Vol. 43, Iss. 4, pp. 315-327
Closed Access | Times Cited: 26
High-throughput quantification of emerging “nitazene” benzimidazole opioid analogs by microextraction and UHPLC–MS-MS
Maria Schüller, Ivana Lučić, Åse Marit Leere Øiestad, et al.
Journal of Analytical Toxicology (2023) Vol. 47, Iss. 9, pp. 787-796
Open Access | Times Cited: 16
Shifting drug markets in North America - a global crisis in the making?
Maximilian Meyer, Jean N. Westenberg, Kerry L. Jang, et al.
International Journal of Mental Health Systems (2023) Vol. 17, Iss. 1
Open Access | Times Cited: 15
Binding preference at the μ-opioid receptor underlies distinct pharmacology of cyclopropyl versus valeryl analogs of fentanyl
Bing Xie, Valerie P. Le Rouzic, Alexander Goldberg, et al.
Neuropharmacology (2023) Vol. 227, pp. 109442-109442
Open Access | Times Cited: 14
Endogenous opiates and behavior: 2022
Richard J. Bodnar
Peptides (2023) Vol. 169, pp. 171095-171095
Closed Access | Times Cited: 13
Metabolic characterization of the new benzimidazole synthetic opioids - nitazenes
Gajanan Raosaheb Jadhav, Pius S. Fasinu
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 5
Plasma pharmacokinetics and pharmacodynamic effects of the 2-benzylbenzimidazole synthetic opioid, isotonitazene, in male rats
Sara E. Walton, Alex J. Krotulski, Grant C. Glatfelter, et al.
Psychopharmacology (2022) Vol. 240, Iss. 1, pp. 185-198
Closed Access | Times Cited: 19
Rapid screening of 2‐benzylbenzimidazole nitazene analogs in suspect counterfeit tablets using Raman, SERS, DART‐TD‐MS, and FT‐IR
Martin M. Kimani, Sara E. Kern, Adam Lanzarotta, et al.
Drug Testing and Analysis (2023) Vol. 15, Iss. 5, pp. 539-550
Closed Access | Times Cited: 12
Page 1 - Next Page

Scroll to top